PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 13(Suppl_2): 480-483 1993
© 1993 International Society for Peritoneal Dialysis
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Digenis, G.
Right arrow Articles by Tourkantonis, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Digenis, G.
Right arrow Articles by Tourkantonis, A
Peritoneal Dialysis International, Vol 13, Issue Suppl_2, S480-S483
Copyright © 1993 by International Society for Peritoneal Dialysis


Articles

Procollagen type-I in the serum and dialysate of continuous ambulatory peritoneal dialysis patients

GE Digenis, NV Dombros, M Christophoraki, I Grapsa, N Savidis, J Datseris, E Samuilidou, N Zerefos, and A Tourkantonis

Renal Unit, Alexandra Hospital, Athens, Greece.

Procollagen-I carboxylterminal extension peptide (PICP) was determined in the serum and dialysate of 26 continuous ambulatory peritoneal dialysis (CAPD) patients and in the serum of 11 healthy controls. PICP serum levels were significantly higher in CAPD patients than in healthy controls (p < 0.001). There was no correlation between serum PICP levels and those of calcium, phosphorus, magnesium, alkaline phosphatase, osteocalcin, and intact parathyroid hormone (iPTH). Serum and dialysate levels of osteocalcin and iPTH showed a significant correlation (p < 0.001). The dialysate-to-serum PICP ratio in 21 patients was lower than 1.0. In the remaining 5 patients, however, the above ratio was higher than 1.0. We conclude that in CAPD patients serum PICP levels do not correlate with biochemical parameters of renal osteodystrophy. A dialysate-to-serum PICP ratio above 1.0 could implicate an increased local peritoneal fibroblastic activity and could be a useful marker of peritoneal fibrosis in CAPD.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 1993 by Multimed Inc.